ALX ONCOLOGY HOLDINGS INC·4

Jan 23, 6:19 PM ET

Shantharam Harish 4

4 · ALX ONCOLOGY HOLDINGS INC · Filed Jan 23, 2025

Insider Transaction Report

Form 4
Period: 2025-01-21
Shantharam Harish
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-01-21+600,000600,000 total
    Exercise: $1.65Exp: 2035-01-20Common Stock (600,000 underlying)
Footnotes (1)
  • [F1]One-fourth of the shares subject to the option vest on January 21, 2026 and 1/48 of the shares vest monthly thereafter.

Documents

1 file
  • 4
    form4-01232025_110129.xmlPrimary